Delivery Order SPE2DB20D1100-SPE2DB25FA5D9

Award Date 2/7/25
Potential Completion Date 2/10/25
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,477.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4564821283 COSOPT EYE DROPS 10ML, a pharmaceutical product, with a completion date of June 6, 2024. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,726.34, is for the delivery of COSOPT EYE DROPS 10ML. This is a firm fixed-price delivery order contract with an ultimate completion date of December 19, 2023. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,783.99, is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, which is valued at $999,999,999 and runs through November 2026. The contract is for the supply of COSOPT EYE DROPS 10ML, a pharmaceutical product, to support military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $28,576.43, is for the delivery of COSOPT PF Eye Drops 15S, a pharmaceutical product. The contract is a Delivery Order under the DLA's Indefinite Delivery Contract (IDC) with Cencora, Inc., doing business as Amerisourcebergen, valued at up to $999,999,999.00. This IDC serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of COSOPT EYE DROPS 10ML. The contract has a ceiling value of $1,792.07 and a completion date of April 4, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
This federal contract award, valued at $2,764.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of 4555781392 - COSOPT PF EYE DROPS 60S, with a completion date of December 27, 2021. The award is structured as a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COSOPT PF eye drops, a specialized ophthalmic medication, with a ceiling value of $1,914.73 and a period of performance through May 1, 2023. The contract is a Delivery Order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA,...
This federal contract award is for the delivery of COSOPT EYE DROPS 10ML to the Defense Logistics Agency. The $1,144.50 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through December 11, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract that Amerisourcebergen holds with the Defense Logistics Agency Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a $8,146.06 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of COSOPT EYE DROPS 10ML. This order was placed under the DLA Troop Support Medical Indefinite Delivery Contract, a $999,999,999 vehicle that provides a wide range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside designation and is scheduled for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,363.70, is a Firm Fixed Price Delivery Order for the supply of Cosopt eye drops. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA5D9
    Delivery Order

This federal contract award, valued at $3,355.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567201814 - COSOPT EYE DROPS 10ML, a type of pharmaceutical eye drops.

The contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and there is no information provided about any subcontractors. The contract has a firm fixed price pricing type and a completion date of February 10, 2025.

Generated 5/9/25, 10:05 AM